Close Menu

NEW YORK (360Dx) — True Diagnostics announced today that it has received 510(k) clearance from the US Food and Drug Administration for its VeriClear Digital Early Result pregnancy test.

According to the Carlsbad, California-based company, the point-of-care test is designed to detect human chorionic gonadotropin levels in women. It is self administered and can detect pregnancy as early as six days before a first missed period, providing a "yes" or "no" result.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.